Kee, Kevin,Penachio, Ernest D.,Kamerkar, Abhijit,Lipp, Michael M.,Batycky, Richard
申请号：
AU2018204674
公开号：
AU2018204674A1
申请日:
2018.06.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018204674A120180712.pdf#####Abstract The present invention provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L. The invention further provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L wherein the capsules shell comprises hydroxypropylmethylcellulose (HPMC) and titanium dioxide.
